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Pemphigus i a severe, blistering disease of the skin and mucous membranes. There 
is loss of epidermal cohesion manifested clinically by induction of intraepidermal 
blisters and erosions with mechanical trauma (Nikolski's sign). Biopsies of lesional 
skin reveal rounding up of epidermal cells with loss of epidermal cell adhesion: this 
pattern is referred to as acantholysis. Two major types of pemphigus are distinguished 
clinically and histopathologically. Pemphigus vulgaris exhibits extensive rosions and 
the vesicles form just above the basal layer of epidermal cells. In contrast, pemphigus 
foliaceous has very shallow blisters that appear in the more superficial granular layer 
of the epidermis. 
In 1964, Beutner and Jordan (1) demonstrated that serum from pemphigus patients 
contained autoantibodies that bound to an intercellular substance of skin and mucosa. 
Skin biopsies revealed in vivo deposition of autoantibodies in the epidermis of 
pemphigus patients (2). Recently, immunoflorescence techniques have shown that 
pemphigus antibody binds to the surface of mouse epidermal cells (3-5), human 
epidermal ceils (5, 6), squamous cell carcinoma lines (7, 8), and a cervical carcinoma 
cell line (K. Singer, unpublished results). 
Michel and Ko (9) reported that incubation of pemphigus antibody with organ 
cultures of normal human skin resulted in histologic hanges identical to those seen 
in biopsies of skin from pemphigus patients. Schiltz and Michel (10) showed that the 
IgG fraction of serum was responsible for loss of cellular adhesion in a complement- 
independent manner. 
Our laboratory (3) presented evidence that a proteinase was responsible for the 
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acantholysis found in pemphigus. Incubation of cultured mouse epidermal cells with 
pemphigus antibody resulted in detachment of cells from the culture vessel. Detach- 
ment was blocked by the addition of the proteinase inhibitors soybean trypsin 
inhibitor and alpha2-macroglobulin. These data suggested that after binding of 
pemphigus antibody to the surface of epidermal cells, a proteinase was activated that 
was involved in toss of cell adhesion. Using skin explant cultures, Morioka et al. (11) 
confirmed a role for proteinases in acantholysis. They reported that the acantholysis 
observed after incubation of normal skin with pemphigus IgG was inhibited by 
soybean trypsin inhibitor and pepstatin A, inhibitors of serine and carboxyl protein- 
ases, respectively. 
Plasminogen activators (PA) 1 are serine proteinases that catalyze the conversion of 
plasminogen to plasmin. Recently, the role of PA in the regulation of localized 
proteolysis within the microenvironment of cells has received much attention. A wide 
variety of normal vertebrate adult and embryonic ells produce PA under certain 
circumstances, and this production is highly regulated (for review see ref. 12-14). 
Included among these cells are macrophages (15, 16), granulocytes (17), ovarian 
granulosa cells (18, 19), fibroblasts (20-24), trophoblasts (25), endothelial cells (26), 
and mouse epidermal cells (27). Reich (12) has suggested that the significance of this 
highly regulated enzyme production is that PA is of critical importance in tissue 
remodeling and cell migration. PA levels are elevated in primary malignant umors 
(28), in cells transformed by oncogenic viruses (20, 21, 29), and in cells treated with 
tumor promoters (22, 30-32). PA levels may be modulated by agents uch as hormones 
(17, 25), retinoids (33, 34), and lectins (31). 
Recently, Becker et al. (35) reported that IgG that binds to cell surface antigens 
can modulate PA production in a variety of cell types. Their results suggested the 
possibility that PA might be the serine proteinase stimulated in epidermal cells after 
the binding of pemphigus autoantibody. The studies presented here indicate that 
binding of pemphigus autoantibody to human epidermal cells results in elevated 
levels of both cell-associated and secreted PA, and that PA is involved in the 
pathogenesis of pemphigus. 
Materials and Methods 
Chemicals and Other Materials. Chemicals and supplies were obtained from the following 
sources: Hanks' balanced salt solution, fetal calf serum (FCS), dog serum, and antibiotic/ 
antimycotic from Gibco Laboratories, Grand Island Biological Co., Grand Island, NY; Dul- 
becco's modified Eagle's medim'n (DME) from B & B Research, Baltimore, MD; trypsin, 
mitomycin C, bovine fibrinogen, dexamethasone, Triton X-100, casein, bovine serum albumin, 
aprotinin, and lima bean trypsin inhibitor (LBTI) from Sigma Chemical Co., St. Louis, MO; 
hydrocortisone and cycloheximide from Calbiochem-Behring Corp., La Jolla, CA; cholera toxin 
and Tris from Schwarz/Mann, Orangeburg, NY; Coomassie Blue, Bromphenyl Blue, and 
sodium dodecyl sulfate from Bio-Rad Laboratories, Richmond, CA; lysine-Sepharose and 
protein A-Sepharose from Pharmacia Fine Chemicals, Piscataway, NJ; cluster 6 culture dishes 
from Costar, Data Packaging, Cambridge, MA; Linbro muhiwell plates from Flow Laborato- 
ries, McLean, VA; microfuge tubes from Walter Sarstedt, Inc., Princeton, N J; sodium heparin 
from Upjohn Co., Kalamazoo, MI; epidermal growth factor from Collaborative Research, 
Waltham, MA; Millex 0.45-/un filters from Millipore Corp., Bedford, MA; urokinase reference 
standard from Leo Pharmaceutical Industries, Ballerup, Demnark. 
i Abbreviations u ed in this paper: DME, Dulbecco's modified Eagle's medium; FCS, fetal calf serum; LBTI, 
lima bean trypsin inhibitor; PA, plasminogen activator; PBS, phosphate-buffered saline; Pf, pemphigus 
foliaceous; Pv, pemphigus vulgaris; SDS, sodium dodecyl sulfate; TCA, trichloroacetic a id. 
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Epidermal Cell Cultures. Human epidermal cells from newborn foreskins were cultured using 
a modification of the technique of Rheinwald and Green (36). Foreskins were obtained within 
3 h of circumcision and incubated briefly in antibiotic- and antimycotic-containing t ssue 
culture medium. After removal of fatty tissue, the foreskin was placed epidermal side down in 
0.25% trypsin in Hanks' balanced salt solution and incubated at 4°C for 18-24 h. The epidermis 
was then easily removed from the dermis and teased with forceps to obtain a cell suspension. 
Cellular debris was allowed to settle and the cells remaining in suspension were plated into the 
wells of Costar cluster 6 tissue culture dishes (1-2 × 105 cells/8 cm 2 well), which had been 
seeded with mitomycin C-treated (15 #g/ml, 2 h, 37°(3) mouse 3T3 fibroblasts (CCL 92; 
American Type Culture Collection, Rockville, MD). Epidermal cells were grown in DME 
supplemented with FCS to a final concentration f 20%, 20 ng/ml epidermal growth factor, 0.4 
#g/ml hydrocortisone, 10 -x° M cholera toxin, 100 U/ml penicillin, 100/zg/ml streptomycin, 
and 0.25/zg/ml fungizone (antibiotic/antimycotic). Cultures were confluent within 3-5 wk. All 
experiments were performed on cell cultures that had reached confluence. 
Harvest of Conditioned Medium and Cell Lysates. After reaching confluence, the cells were 
incubated overnight with DME containing 20% FCS and no other additives. The cultures were 
then incubated with DME (1 ml/well) with or without IgG. 24 h later this conditioned medium 
was harvested, centrifuged at 6,500 g for 5 min, and assayed for extracellular PA activity using 
the fibrin plate method escribed below. The cells were then washed three times with phosphate- 
-buffered saline (PBS), pH 7.3, and treated with 0.5% Triton X-100 in 0.01 M Tris-HC1, pH 
7.8, for 5 min at 4°C (1 ml/well). The wells were scraped with a rubber policeman and the 
contents were transferred toa 1.5-ml microfuge tube and centrifuged at 6,500 g for 5 min. The 
supernatant (cell lysate) was assayed to determine cell-associated PA activity. The wells used in 
a single experiment contained cells originating from the same foreskin. Preliminary experiments 
documented that, at confluence, the cell number in different wells from a single foreskin varied 
by <15% (data not shown). Cell numbers were not routinely determined in each well because 
it was desirable to obtain cell lysates from each well. Determination f cell numbers would have 
required trypsinization, which would have altered cell viability and introduced trypsin-related 
artifacts. 
IgG Preparations. Preparations of pemphigus vulgaris (Pv) IgG from two patients were 
studied. The source of Pv IgG used in the majority of experiments was the kind gift of Dr. 
Joseph McGuire, Department of Dermatology, Yale University Medical Center. The patient 
was a 49-yr-old female with a 3-yr history of Pv, who at the time of plasma collection had a 
flare up of her disease. Her serum had an indirect immunofluorescence pemphigus antibody 
titer of 1:320. IgG preparations from three patients with pemphigus foliaceous (Pf) were also 
studied. The results presented here were obtained primarily from serum and plasma collected 
from an 18-yr-old male patient at Duke University Medical Center. Clinical examination and 
histological examination were consistent with a diagnosis of Pf. These findings were confirmed 
by immunofluoreseent xamination of his skin biopsy, which showed deposition of IgG in the 
intercellular spaces of the epidermis. Indirect immunofluorescence revealed a serum pemphigus 
antibody titer of 1:80. None of the patients tudied had received therapy for their disease at the 
time of serum or plasma collection. Serum and plasma were also collected from normal donors. 
IgG was prepared from patient serum and plasma nd from normal serum and plasma by 
affinity chromatography. After single-step isolation of IgG using the standard technique of 
affinity purification on Staphylococcal protein A-Sepharose (37), we detected plasminogen as
a contaminant in IgG preparations (38). Consequently, IgG was routinely isolated free of 
plasminogen by sequential column chromatography on lysine-Sepharose, which binds plasmin- 
ogen (39), followed by protein A-Sepharose. All IgG preparations used in the experiments 
described were isolated in this manner. Briefly, the serum was diluted twofold in 0.1 M 
phosphate buffer, pH 7.0, and applied to a column of lysine-Sepharose that had been 
equilibrated with the same buffer. The lysine-Sepharose column was connected irectly to a 
column of protein A-Sepharose equilibrated with the starting buffer. After the sample had run 
from the lysine-Sepharose column into the protein A-Sepharose column, the latter was washed 
extensively with 0.1 M phosphate buffer, pH 7.0, and the IgG was eluted with 0.1 M glycine- 
HCI in 0.15 M NaCI, pH 3.0. When IgG was prepared from plasma, 5 U/ml sodium heparin 
was included in all buffers. Fractions containing I G were pooled and neutralized using 1 M 
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Tris. Protein concentrations were determined and adjusted to 8-10 mg/ml.  The IgG prepara- 
tions were dialyzed against DME and filter-sterilized using Millex 0.45-/Lm filters. IgG prepa- 
rations isolated in this manner were incubated with urokinase and assayed by the lzsI-fibrin 
plate assay described below to confirm that the immunoglobulin was free of plasminogen. 
PA Assay. PA was assayed using multiwell culture dishes coated with 125I-fibrin. Bovine 
fibrinogen, free of plasminogen, was prepared according to the method of Laki (40) and 
Mosesson (41) and iodinated using chloramine T (42). 12~I-fibrin-coated muhiwell dishes were 
prepared according to Strickland and Beers (19). Each well (surface area 2 cm 2) was coated 
with 25 #g ~zsI-fibrinogen (~4,000 cpm//Lg). Conversion of fibrinogen to fibrin was accomplished 
by a 2-h incubation at 37°C with DME supplemented with 5% plasminogen-depleted f tal 
bovine serum. Each well was washed twice with PBS. Immediately before assay, the wells were 
washed with 0.1 M Tris-HCl, pH 8.1. The reaction mixture contained 50 #1 of samples (either 
cell lysates or conditioned medium) and 1.2 p.g of dog plasminogen, purified from dog serum 
(39) in a total volume of 300/~i of 0.1 M Tris-HC1, pH 8.1. The dishes were incubated for 60 
min at 37°C, after which the supernatant was collected and the release of 12SI-labeled peptides 
from the '2~I-fibrin was quantitated using an LKB model 1270 RackGamma II gamma counter 
(LKB Instruments, Inc., Turku, Finland). 
PA activity in conditioned medium and cell lysates was compared with the activity of a 
standard preparation of human urokinase measured on the same day. In each assay, a standard 
curve of PA activity was generated over a range of 1.6-25 Ploug milliunits (mU) of urokinase 
activity. All samples were diluted to fall within the linear range of the standard curve. All 
assays were performed in duplicate and duplicates varied by __.10%. The PA activity in each 
sample was computed from the standard curve using the RackGamma radioimmunoassay data 
reduction system. 
Because the number of cells in confluent wells originating from the same foreskin differed by 
~15%, the PA activity in the samples was expressed as units of activity per well. Extracellular 
activity was expressed as Ploug milliunits per milliliter conditioned medium collected from one 
well of a Costar cluster 6 plate (surface area 8 cm2). Cell-associated PA activity is expressed as 
Ploug milliunits per milliliter cell lysate extracted from one well. 
Skin Explant Cultures. Skin explants were cultured by the method of Morioka et al. (11). 
Skin was obtained aseptically after face and neck lift surgery, reduction mammoplasty, or 
laparotomy. After removal of fatty tissue, the skin was cut into pieces ~3 X 3 ram. The pieces 
of skin were placed dermis-side down on paraffin-rimmed lens paper rafts and floated on 1 ml 
of tissue culture medium with or without IgG and/or plasminogen and proteinase inhibitors. 
After appropriate incubation, the skin was processed for tissue sectioning, stained with hema- 
toxylin and eosin and observed microscopically using a Zeiss universal microscope (Carl Zeiss, 
Inc., New York). 
Electrophoretic Analysis of PA. The eleetrophoretic analysis of epidermal cell PA was per- 
formed by the method of Vetterlein et al. (43). Conditioned medium was collected from 
cultured epidermal cells incubated with or without pemphigus IgG. Samples collected from 
cells treated with IgG were preabsorbed with protein A Sepharose (0.9 ml sample plus 0.1 ml 
protein A Sepharose, 4°C, 2 h) to remove the IgG. The samples were then dialyzed to a buffer 
of 0.06 M Tris, pH 6.8 containing 2.3% sodium dodecyl sulfate (SDS), 10% glycerol, and 0.005% 
Bromphenyl Blue. Electrophoresis was carried out in slab gels using 0.1% SDS, a 12.5% 
polyacrylamide running gel, a 5% polyacrylamide stacking gel, and the Laemmli buffer system 
(44, 45). The gel was removed from the glass plates, agitated in 2.5% Triton X-100 in 0.1 M 
Tris-HC1, pH 8.1, at 22°C for 1 h, and each lane was cut into 2-ram slices. Each gel slice was 
assayed for PA activity in the lz~I-fibrin plate assay described above. 
Assay for Cathepsin D Using [all]Hemoglobin as Substrale. Jail]Hemoglobin was prepared 
according to Levine et al. (46). 5 ~1 of sodium acetate buffer (1.2 M, pH 7.2), 5/.tl of water, and 
30/~1 of sample were incubated at 37°C with 20/~1 of [3H]hemoglobin (~300,000 cpm) in 0.4- 
ml polypropylene microfuge tubes for 2 h. After incubation, 40 ~1 of a 50 mg/ml  solution of 
bovine serum albumin was added to each tube as carrier protein. 100 ~1 of a solution of 6% 
trichloroacetic acid (TCA) was added to each tube and the resulting precipitate was pelleted at 
6,500 g in a microfuge. 100 ~1 of the supernatant was removed from each tube and counted in 
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an Intertechnique liquid scintillation counter (Intertechnique, Zurich, Switzerland). In this 
assay, 1/,g/ml pepsin caused the release of 5,000 cpm of 3H-labeled TCA-soluble peptides. 
Results 
Pemphigus IgG Stimulates Extracellular nd Cell-associated PA. Confluent cultures of 
human epidermal cells were incubated for 24 h with various concentrations of Pf IgG, 
Pv IgG, or normal human IgG. The conditioned medium and cell lysates were then 
assayed for PA as described above (Fig. 1). These data are pooled from several 
different experiments and are expressed as percent of control. Production of PA was 
IgG dose dependent. Incubation of epidermal cells with normal human IgG resulted 
in a slight increase (1.7-fold) in extracetlular PA at all concentrations tested and no 
increase in cell-associated PA. Incubation of epidermal cells with Pf IgG resulted in 
a 10-fold increase in extracellular PA and a 5-fold increase in cell-associated PA. The 
stimulation of both extracellular and cell-associated PA reached a maximum at 2 
mg/ml. At higher concentrations of IgG, less stimulation was observed. Incubation of 
epidermal cells with Pv IgG resulted in a sevenfold increase in extracellular PA and 
a sixfold increase in cell-associated PA. The stimulation of both extracellular and cell- 
associated PA by Pv IgG reached a maximum at 0.5 mg/ml IgG. In other experiments, 
the stimulation of PA by 0.25 mg/ml of Pv IgG was not as great as that seen with 0.5 
mg/ml (data not shown). By adding IgG to samples of conditioned medium collected 
from cells incubated with stimulatory concentrations of IgG, we observed that the 
higher concentrations of IgG did not inhibit the fibrin plate assay (data not shown). 
We also tested one additional Pv IgG preparation and two additional Pf IgG 
preparations. All three stimulated PA in epidermal cells in a dose-dependent manner 
(data not shown). 
Fig. 2 shows the kinetics of PA stimulation by an optimal concentration of Pf IgG 
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FIG. 1. Stimulation of PA production by pemphigus IgG. Confluent cultures of human epidermal 
cells were incubated with various concentrations of normal human IgG ( i ) ,  Pv IgG (&), or Pf IgG 
(O) for 24 h at 37°C. Conditioned medium was collected and extracellular PA was quantitated 
using the 12sI-fibrin plate assay as described in Materials and Methods (panel A). Cell lysates were 
prepared using Triton X-100 and cell-associated PA was quantitated (panel B). 
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FIG. 2. Time course ofpemphigus IgG stimulation of PA production. Confluent cultures of human 
epidermal cells were incubated with normal human IgG (2 mg/ml) (A), or Pf IgG (2 mg/ml) (0) 
for 6-24 h at 37°C. Extracellular (panel A) and cell-associated (panel B) PA was quantitated using 
the 125I-fibrin plate assay. 
(2 mg/ml).  By 6 h, extracellular PA in cultures incubated with Pf  IgG had risen to 
200 mU/ml ,  or approximately four times that of the cultures incubated with 2 mg/  
ml normal human IgG. By 12 h, the extracellular PA levels had risen slightly in the 
Pf cultures but remained the same in the presence of normal IgG. Between 12 and 24 
h there was a dramatic increase in the extracellular PA in the presence of Pf IgG to 
1,600 mU/ml  or ~10 times that in cultures treated with normal IgG for 24 h. 
Maximum levels of cell-associated PA were reached somewhat earlier. By 6 h about 
three times more cell-associated PA was detected in Pf IgG-treated cultures as that 
found in normal IgG-treated cultures. By 12 h, 70 mU/ml  cell-associated PA was 
detected in Pf IgG-treated cultures, more than nine times that detected in normal 
IgG-treated cultures. The amount of cell-associated PA rose only slightly between 12 
and 24 h, the time during which a dramatic increase in extracellular PA was observed. 
Antibody Stimulation of PA Is Not Associated with Release of Lysosomal Enzyme Activ- 
ity. We have documented in previous studies (3, 6) (using trypan blue exclusion, 
retention of ~lCr, and incorporation of radiolabeled amino acids into protein) that 
pemphigus antibody in the absence of complement is not cytotoxic for human or 
mouse epidermal cells, or for a human cervical carcinoma cell line (unpublished 
results). It was important to determine whether the increased enzyme activity we 
observed is related to cell damage undetected by the above methods or to regurgitation 
of lysosomal contents during endocytosis. The conditioned medium was assayed for 
cathepsin D as a marker for the release of Iysosomal enzymes (46). Epidermal cells 
were incubated for 24 h with IgG preparations at various concentrations up to 8 mg/  
ml and the medium was then tested for the ability to hydrolyze [3H]hemoglobin 
(Table I). Medium from cells incubated with 8 mg/ml  IgG had slightly higher enzyme 
activity than that from cells incubated without IgG. Medium collected from cells 
incubated with 0.5 mg/ml  IgG, which is the opt imum for PA stimulation, hydrolyzed 
hemoglobin to the same extent as that collected from cells incubated without IgG. 
We conclude that the antibody-mediated stimulation of PA activity is not related to 
cell damage and is not accompanied by a generalized secretion of lysosomal enzymes. 
Pemphigus Antibody-induced PA Stimulation Requires Protein Synthesis. Epidermal cells 
were incubated for 12 h with Pf IgG in the presence of various concentrations of 
cycloheximide (Fig 3). 20 /~g/ml cycloheximide inhibited extracellular and cell- 
associated PA by 95 and 90%, respectively. This concentration of cycloheximide 
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TABLE [ 
Hydrolysis of/~H]Hemoglobin by Conditioned Medium from Human 
Epidermal Cells Incubated with Pv IgG 
]g,G ~H peptides released* 
mg/ml cpm 
8 1,316 _+ 78~: 
4 1,093 -+ 46 
2 781 ___ 58 
1 740 ___ 95 
0.5 920 _.+ 26 
0 913 _+ 68 
* 5,000 cpm were released in the presence of 1 gg/ml pepsin. 
~_+SD. 
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FI~. 3. Inhibition by cyeloheximide of pemphigus IgG-stimulated PA production. Confluent 
cultures of human epidermal cells were incubated for 12 h at 37°C with Pf IgG (2 mg/ml) in the 
presence of various concentrations of cycloheximide. Extracellular (0) and cell-associated (A) PA 
were quantitated using the x2~I-fibrin plate assay. Control values in the presence ol r antibody but 
absence of cyclohexirnide were 685 mU/ml  in cell lysates and 2,306 mU/ml  in conditioned medium. 
inhibited incorporation of [ass]methionine into proteins by 82% (data not shown). 
These data confirm that intact, metabolically active cells are required for the 
stimulation of PA by pemphigus IgG. 
Inhibition by Dexamethasone of Pf IgG Stimulation of PA. Epidermal ceils were incu- 
bated for 24 h in the presence of Pf IgG and various concentrations of the steroid 
dexamethasone (Fig. 4). At ~0 -~° M, extracel]u~ar PA activity was inhibited by 60%. 
At I0 -s M, 95% inhibition of antibody-induced PA was achieved. Stimulation of PA 
production by cells treated with lectins (31) and phorbol esters (30, 31), as well as by 
thioglycollate-stimulated macrophages (15), has been reported to be inhibited by the 
same concentrations of steroids. The inhibitory concentrations of dexamethasone 
approximate those used in the clinical treatment of pemphigus. 
Electrophoresis ofAntibody-stimulated PA. Two major types of human PA are distin- 
guished both biochemically and immunologically. The "urokinase type" has a molec- 
ular weight of 52,000-55,000, whereas the "tissue factor type" has a molecular weight 
of 68,000-74,000 (23, 26, 43). Samples of conditioned medium from cells incubated 
with or without pemphigus IgG were analyzed for PA activity after electrophoresis on 
SDS polyacrylamide gels. The electrophoretic profile of enzymatic activity indicated 
that the major peak of PA activity secreted by unstimulated cultured human 
epidermal cells is of a molecular weight of ~55,000 (Fig. 5 A). A trailing of enzymatic 
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Fro. 4. Inhibition by dexamethasone of pemphigus IgG-stimulated PA production. Confluent 
cultures of human epidermal cells were incubated for 24 h at 37°C in the presence of Pf IgG (2 rag/ 
ml) in the presence of various concentrations of dexamethasone. Extrace|lular PA (0) was quanti- 
tated using the ~z~I-fibrin plate assay. Control value in the absence of dexamethasone was 1,576 
mU/ml .  
activity was seen at higher molecular weights. The small peak of activity at 36,000 
mol wt is probably a degradation product of the urokinase type PA, as it also 
appeared when purified urokinase was electrophoresed as a standard. The electropho- 
retic profile of conditioned medium from cells treated with Pv IgG (Fig. 5 B) or Pf 
IgG (Fig. 5C) was not different from untreated cells. These data suggest that 
pemphigus antibody stimulates the production of PA normally produced by cultured 
human epidermal cells. 
Skin Explants. To investigate the role of antibody-induced increases in PA on the 
loss of epidermal cohesion, skin explant experiments were performed in the presence 
or absence of pemphigus IgG, human plasminogen, and a variety of proteinase 
inhibitors. When normal human skin was incubated for 48 h with IgG from Pv 
patients (4 mg/ml), histologic hanges resembling Pv occurred (Fig. 6A). The onset 
of these changes appeared to be hastened by the inclusion of human plasminogen 
(200 /~g/ml); however, a strict dependence upon exogenous plasminogen was not 
demonstrated ( ata not shown). No acantholysis was seen in skin explants incubated 
with Pf IgG (4 mg/ml) (Fig. 6 B); however, when human plasminogen (200 ffg/ml) 
was included along with Pf [gG (4 mg/ml), acantholysis n the upper epidermis was 
consistently observed (Fig. 6C). No acantholysis was seen in explants incubated with 
human plasminogen alone (200 ffg/ml) (data not shown). When aprotinin, which 
inhibits plasmin but not PA (47), was included with Pf IgG and plasminogen, 
production of acantholysis was inhibited (Fig. 6D). Identical results were obtained 
using LBTI, which also inhibits plasmin but not PA (47). Both aprotinin and LBTI 
were also able to inhibit acantholysis in explants incubated with Pv IgG and 
plasminogen (data not shown). In an effort to further implicate plasmin as having a 
role in acantholysis, kin explants were incubated with plasmin. Acantholytic hanges 
were not observed in explants incubated with 3 Sigma U/ml. At higher concentrations, 
the plasmin was toxic to the explants. It is possible that activation of plasminogen by 
antibody-induced PA results in high, localized concentrations of plasmin that were 
not achieved when explants were incubated with plasmin. 
Discussion 
Binding of pemphigus autoantibody to epidermal cells stimulated both secreted 
and cell-associated PA in a time- and dose-dependent manner. The increase in PA 
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Fro. 5. Electrophoretic profile of PA activity in conditioned medium collected from human 
epidermal cells incubated at 37°C. (A) without IgG, (B) with Pv IgG (1 mg/ml), (C) with Pf lgG 
(2 mg/ml). 1.5-2.5 Ploug units/nl of urokinase quivalent activity were applied to each lane of a 
slab 12.5% polyacrylamide g l and electrophoresed. The gel was agitated in 2.5% Triton X-100 for 
1 h at 22°C and each lane was sliced into 2-ram slices. The PA activity in each gel slice was 
quantitated using the 12sI-fibrin plate assay. 
was not due to cytotoxicity and was not accomplished by a generalized secretion of 
lysosomal enzymes. St imulat ion of PA after interaction of pemphigus ant ibody and 
epidermal  cells was dependent upon protein synthesis and was prevented by dexa- 
methasone. The molecular species of PA st imulated by both Pv and Pf IgG appeared 
to be the same as that found in cultured human epidermal  cells not treated with ]gG, 
and the major peak of PA activity co-migrated in SDS polyacry lamide gels with the 
high-molecular-weight band of  urokinase (~55,000). 
Explants of human skin incubated with plasminogen and Pf  IgG underwent 
acantholyt ic changes identical to those found in biopsies of Pf  patients. Acantholysis 
was inhibited by aprot in in and LBTI.  Skin explants incubated with Pv IgG showed 
histological changes identical to those seen in patients with Pv. The inclusion of 
plasminogen hastened the onset of acantholysis in skin explants incubated with Pv 
268 PEMPHIGUS-STIMULATED PLASMINOGEN ACTIVATOR ACTIVITY 
FIG. 6. Explants of normal human skin were incubated for 48 h at 37°C with (A) Pv IgG (4 mg/ 
ml); (B) PfIgG (4 mg/ml); (C) PfIgG (4 mg/ml) plus plasminogen (200 ~g/ml); (D) PfIgG (4 mg/ 
ml), plasminogen (200 ~g/ml), aprotinin (a total of 60 trypsin inhibitory units wa added in doses 
of 20 trypsin inhibitory units at 0 time, 20 h, and 30 h). X 600. 
IgG. This observation is consistent with a recent report by Isseroff and Rifkin (48), 
who found that plasminogen was preferentially deposited on the basal layer of 
epidermis. In organ culture experiments using Pv IgG, exogenously added plasmino- 
gen might not be necessary if plasminogen is already present on the basal cells of the 
epidermis. 
The results presented here provide evidence for autoantibody-mediated r gulation 
of a specific disease process by activation of proteolytic enzymes. Our  data support 
the following molecular mechanism for the autoimmune disease pemphigus. Binding 
of pemphigus autoantibody to the surface of human epidermal cells stimulates the 
production of PA, In the presence of plasminogen, the increased levels of PA result in 
an increased conversion of plasminogen to plasmin. Plasmin is then responsible for 
loss of cellular adhesion, probably by degradation of cell surface molecules responsible 
for cell-cell adhesion within the epidermis. The plasmin-induced issolution of the 
intercellular matrix results in acantholysis, which is the hallmark of pemphigus. 
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The significant mortality from pemphigus was greatly reduced when corticosteroid 
therapy became available (49). Corticosteroids in high doses rapidly and dramatically 
reverse blister formation in pemphigus. In our experience, high-dose methyl prednis- 
olone pulse therapy resulted in clearing of blisters within 48 h (G. S. Lazarus, 
unpublished results). Pemphigus antibody titers, however, drop significantly only 
after 2-4 mo of steroid therapy, and some patients become clinically free of disease 
while still possessing an antibody titer (50). The data presented in this report are 
compatible with the hypothesis that corticosteroids act by inhibiting antibody stim- 
ulation of proteinase activation. 
Summary  
Binding of anti-cell surface pemphigus autoantibodies to cultured human epidermal 
cells stimulates synthesis and secretion of plasminogen activator (PA). Increases in PA 
activity were detected within 6 h of the addition of IgG and stimulation was dependent 
upon IgG concentration. Stimulation of PA activity was inhibited by cycloheximide, 
which indicates that synthesis of protein was necessary. Pharmacological doses of 
dexamethasone also prevented IgG-induced stimulation of PA. Electrophoretic pro- 
files of PA secreted by cultured human epidermal cells in the presence or absence of 
pemphigus IgG were similar. The majority of the PA activity comigrated with the 
higher-molecular-weight species of human urokinase (~55,000). Explants of normal 
human skin incubated with pemphigus vulgaris IgG displayed loss of epidermal 
cohesion similar to that observed in patient biopsies. The histologic changes were 
potentiated by the inclusion of human plasminogen. Loss of epidermal cohesion in 
normal skin explants incubated with pemphigus foliaceous IgG was dependent upon 
the addition of plasminogen and was inhibited by aprotinin or lima bean trypsin 
inhibitor, which indicated that plasmin is the active enzyme in producing acantholysis. 
These data support the hypothesis that stimulation of PA by the anti-cell surface 
autoantibodies of pemphigus results in a localized increase in plasmin, which through 
proteolysis produces the loss of epidermal cohesion characteristic of pemphigus. 
We would like to thank Dr. Shinji Morioka, who provided vital help in the performance of the 
skin explant experiments, Dr. Joseph McGuire for plasma from a pemphigus patient, and Mrs. 
Marcia Beard for excellent secretarial ssistance. 
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